Jefferies Group’s Starling Oncology, Inc. Warrant STLNW Stock Holding History

Jefferies Group’s Portfolio STLNW Stock Details STLNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$52.6K	Hold	95,200	–	–	﹤0.01%	1511
2022 Q2	$47.6K	Sell	95,200 -60,257	-39%	-$55.4K	﹤0.01%	1406
2022 Q1	$179K	Sell	155,457 -19,543	-11%	-$17.8K	﹤0.01%	1285
2021 Q4	$121K	Buy	175,000 +135,340	+341%	+$167K	﹤0.01%	1453
2021 Q3	$50.4K	Hold	39,660	–	–	﹤0.01%	1604
2021 Q2	$68.6K	Hold	39,660	–	–	﹤0.01%	1525
2021 Q1	$47.6K	Sell	39,660 -10,465	-21%	-$19.4K	﹤0.01%	1512
2020 Q4	$97.7K	Hold	50,125	–	–	﹤0.01%	1460
2020 Q3	$85K	Hold	50,125	–	–	﹤0.01%	1256
2020 Q2	$74	Buy	+50,125	New	+$71.9K	﹤0.01%	1141

Other funds holding STLNW

LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

USPCM

Union Square Park Capital Management New York $176M AUM 51.52% 1-Year Est. Return

DCM

Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return

Jefferies Group's STLNW Position: Q3 2022 in Review

Jefferies Group held its Starling Oncology, Inc. Warrant (STLNW) position steady in Q3 2022 at 95,200 shares worth $52.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1511.

Jefferies Group first reported a position in STLNW in Q2 2020 and has held it in 10 quarters since. The position peaked at $179K in Q1 2022. 12 funds tracked by Wall St. Rank hold STLNW as of Q3 2022.

Jefferies Group held 95,200 shares of Starling Oncology, Inc. Warrant worth $52.6K as of Q3 2022.
Jefferies Group left its Starling Oncology, Inc. Warrant share count unchanged in Q3 2022.
Starling Oncology, Inc. Warrant made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1511 holding.
Jefferies Group first reported a position in Starling Oncology, Inc. Warrant in Q2 2020 and has held it in 10 quarters since.
Jefferies Group's Starling Oncology, Inc. Warrant position peaked at $179K in Q1 2022.
12 funds tracked by Wall St. Rank held Starling Oncology, Inc. Warrant as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.